Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Zycubo
.
Show all posts
Showing posts with label
Zycubo
.
Show all posts
Thursday, July 16, 2026
FDA Approves Zycubo (copper histidinate) for Children With Menkes Disease
›
Sentynl Therapeutics Inc. (“Sentynl”), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences Limited (“Zydus Group”), an...
Wednesday, July 15, 2026
FDA Approves Zycubo (copper histidinate) for Children With Menkes Disease
›
Sentynl Therapeutics Inc. (“Sentynl”), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences Limited (“Zydus Group”), an...
›
Home
View web version
